We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Pentair
PNR
$10.2B
| $706K | ﹤0.01% |
13,531
+356
| +3% | +$16.6K |
|
|
AGN
577
DELISTED
Allergan plc
AGN
| $697K | ﹤0.01% |
+4,150
| New | +$649K |
|
578
Carnival Corporation Ltd
CCL
$36.1B
| $689K | ﹤0.01% |
17,158
+160
| +0.9% | +$5.65K |
|
|
LLL
579
DELISTED
L3 Technologies, Inc.
LLL
| $689K | ﹤0.01% |
6,449
-75
| -1% | -$7.5K |
|
580
Graham Holdings Company
GHC
$4.97B
| $684K | ﹤0.01% |
1,705
| – | – |
|
581
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $684K | ﹤0.01% |
13,409
-1,975
| -13% | -$97.9K |
|
582
Honda
HMC
$36.5B
| $683K | ﹤0.01% |
16,520
| – | – |
|
583
Consolidated Edison
ED
$41.6B
| $676K | ﹤0.01% |
12,229
-2,822
| -19% | -$159K |
|
|
RYL
584
DELISTED
RYLAND GROUP INC
RYL
| $675K | ﹤0.01% |
15,542
| – | – |
|
585
Sanofi
SNY
$104B
| $674K | ﹤0.01% |
12,570
-1,348
| -10% | -$69.6K |
|
586
BlackRock TCP Capital
TCPC
$265M
| $673K | ﹤0.01% |
40,100
| – | – |
|
587
Enbridge
ENB
$124B
| $670K | ﹤0.01% |
15,345
+500
| +3% | +$21.1K |
|
588
Vanguard Small-Cap ETF
VB
$79.5B
| $669K | ﹤0.01% |
6,085
-956
| -14% | -$102K |
|
589
Dentsply Sirona
XRAY
$2.59B
| $667K | ﹤0.01% |
13,750
+2,250
| +20% | +$105K |
|
590
Unum
UNM
$13.8B
| $666K | ﹤0.01% |
18,997
+1,845
| +11% | +$60.4K |
|
591
Capital One
COF
$124B
| $653K | ﹤0.01% |
8,529
+52
| +0.6% | +$3.7K |
|
592
Teekay
TK
$975M
| $653K | ﹤0.01% |
13,600
+500
| +4% | +$21.9K |
|
|
OILT
593
DELISTED
OILTANKING PARTNERS L P UIT LTD PARTNERSHIP INT (DE)
OILT
| $652K | ﹤0.01% |
21,000
| – | – |
|
|
N
594
DELISTED
Netsuite Inc
N
| $644K | ﹤0.01% |
6,250
-500
| -7% | -$50.1K |
|
595
McKesson
MCK
$98.5B
| $636K | ﹤0.01% |
3,945
+651
| +20% | +$100K |
|
596
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.75B
| $632K | ﹤0.01% |
32,330
| – | – |
|
|
MASI
597
DELISTED
Masimo
MASI
| $631K | ﹤0.01% |
21,603
-306
| -1% | -$8.56K |
|
598
Herc Holdings
HRI
$5.43B
| $630K | ﹤0.01% |
+7,337
| New | +$524K |
|
599
York Water
YORW
$505M
| $628K | ﹤0.01% |
30,000
| – | – |
|
600
Vanguard Russell 1000 ETF
VONE
$8.19B
| $625K | ﹤0.01% |
7,339
-296
| -4% | -$24.2K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.